News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-05 6:36:36 am Immix Biopharma Announces “Be Proactive in AL” AL Amyloidosis Awareness Initiative GlobeNewsWire
2024-02-21 6:31:0 am Immix Biopharma 12 Month Review Progress Update GlobeNewswire
2024-02-08 1:45:0 pm Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock GlobeNewswire
2024-02-07 6:37:0 am Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis GlobeNewswire
2024-02-05 7:30:0 pm Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock GlobeNewswire
2024-02-05 12:20:0 pm Immix Biopharma Announces Proposed Public Offering of Common Stock GlobeNewswire
2024-01-24 5:35:0 am Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products GlobeNewswire
2024-01-11 3:25:39 am Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth? Simply Wall St.
2024-01-04 6:34:0 am Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information